SCHEMBL23357110

SCHEMBL23357110

CNC(=O)c1ccc(CC(CN)NC(=O)O)cc1F

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ OPRD1 P41143 4/20 0.45
▸ ROCK2 O75116 3/20 0.41
▸ ROCK1 Q13464 3/20 0.41
▸ PRKACA P17612 2/20 0.41
▸ SGK1 O00141 1/20 0.41
▸ PRKD3 O94806 1/20 0.41
▸ LATS1 O95835 1/20 0.41
▸ PRKCG P05129 1/20 0.41
▸ PRKCB P05771 1/20 0.41
▸ PRKCA P17252 1/20 0.41
▸ PRKACB P22694 1/20 0.41
▸ RPS6KB1 P23443 1/20 0.41
▸ PRKCH P24723 1/20 0.41
▸ MARK3 P27448 1/20 0.41
▸ AKT1 P31749 1/20 0.41
▸ AKT2 P31751 1/20 0.41
▸ PRKCI P41743 1/20 0.41
▸ CSNK1A1 P48729 1/20 0.41
▸ CDK7 P50613 1/20 0.41
▸ CDK16 Q00536 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23357107 1.00 OPRD1 (0.45) OPRD1ROCK2ROCK1PRKACASGK1
SCHEMBL23357080 0.89 MAPK1 (0.50) OPRD1ROCK2ROCK1PRKACAGAA
SCHEMBL23357082 0.89 MAPK1 (0.50) OPRD1ROCK2ROCK1PRKACAGAA
SCHEMBL28563950 0.84 ATM (0.42) OPRD1ROCK2ROCK1PRKACASGK1
SCHEMBL29688160 0.84 ATM (0.42) OPRD1ROCK2ROCK1PRKACASGK1
SCHEMBL21447246 0.84 ATM (0.42) OPRD1ROCK2ROCK1PRKACASGK1
SCHEMBL23357115 0.79 OPRD1 (0.44) OPRD1ROCK2ROCK1PRKACAGAA
SCHEMBL23357112 0.79 OPRD1 (0.44) OPRD1ROCK2ROCK1PRKACAGAA
SCHEMBL23357298 0.79 OPRD1 (0.58) OPRD1GAAOPRM1EPHX2NR1H4
SCHEMBL23357299 0.79 OPRD1 (0.58) OPRD1GAAOPRM1EPHX2NR1H4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11352316-B2 Opioid receptor modulators and products and methods related thereto EPIODYNE, INC. (US) 2022-06-07 — — US disclosed
US-20210163402-A1 OPIOID RECEPTOR MODULATORS AND PRODUCTS AND METHODS RELATED THERETO EPIODYNE, INC. 2021-06-03 — — US disclosed
US-20210147343-A1 OPIOID RECEPTOR MODULATORS AND PRODUCTS AND METHODS RELATED THERETO EPIODYNE, INC. 2021-05-20 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11352316-B2 Opioid receptor modulators and products and methods related thereto OPRM1, OPRD1, OPRK1 OPRD1 2/4885ROCK2 4301/4885ROCK1 2686/4885
US-20210163402-A1 OPIOID RECEPTOR MODULATORS AND PRODUCTS AND METHODS RELATED THERETO OPRM1, OPRD1, OPRK1 OPRD1 2/4885ROCK2 4301/4885ROCK1 2686/4885
US-20210147343-A1 OPIOID RECEPTOR MODULATORS AND PRODUCTS AND METHODS RELATED THERETO OPRM1, OPRD1, OPRK1 OPRD1 2/4885ROCK2 4277/4885ROCK1 2650/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback